Predictions
Aphria Inc.
Start price
Target price
Perf. (%)
€9.43
14.01.21
14.01.21
€28.00
72.92%
12.03.21
12.03.21
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
CRH Medical Corp
Start price
Target price
Perf. (%)
€3.22
08.02.21
08.02.21
€3.00
08.02.22
08.02.22
-0.62%
22.02.21
22.02.21
Good culture
Probably not worthwhile Investment
Little innovation
No uniques
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€2.81
10.01.21
10.01.21
-
10.01.22
10.01.22
7.84%
23.01.21
23.01.21
Risky Investment
Aphria Inc.
Start price
Target price
Perf. (%)
€7.48
11.01.21
11.01.21
-
11.01.22
11.01.22
39.14%
15.01.21
15.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Aphria Inc.
Start price
Target price
Perf. (%)
€4.90
14.11.20
14.11.20
-
14.11.21
14.11.21
23.24%
27.11.20
27.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.76
22.08.20
22.08.20
-
07.09.20
07.09.20
-5.48%
07.09.20
07.09.20
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€26.94
25.05.19
25.05.19
€40.00
27.07.20
27.07.20
-82.97%
27.07.20
27.07.20
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.44
13.03.20
13.03.20
€9.32
24.07.20
24.07.20
-15.48%
24.07.20
24.07.20
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€42.32
29.01.19
29.01.19
€23.00
12.05.20
12.05.20
-66.80%
12.05.20
12.05.20
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€22.73
03.04.19
03.04.19
€27.06
12.03.20
12.03.20
-32.91%
12.03.20
12.03.20
Lifeist Wellness Inc.
Start price
Target price
Perf. (%)
€0.12
19.06.17
19.06.17
€0.38
27.12.19
27.12.19
0.00%
27.12.19
27.12.19
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?0.83
27.05.19
27.05.19
€1.17
15.11.19
15.11.19
0.00%
15.11.19
15.11.19
AEterna Zentaris Inc.
Start price
Target price
Perf. (%)
€89.30
03.02.19
03.02.19
€112.75
05.08.19
05.08.19
-42.42%
05.08.19
05.08.19